Globally, glaucomas are the most frequent cause of irreversible blindness, caused by a build-up of fluid in the eye. Africa has the highest prevalence of the condition and highest prevalence of blindness due to glaucoma. Rates in Sub-Saharan Africa are … Continue reading →

A smartphone-based eye screening and referral system used by community members has been shown to almost triple the number of people with eye problems attending primary care, as well as increasing appropriate uptake of hospital services, compared to the standard … Continue reading →

After a couple of months on BioRxiv our first pre-print has been accepted for publication in Antimicrobial Agents & Chemotherapy! ‘Chemogenomic profiling of anti-leishmanial efficacy and resistance in the related kinetoplastid parasite Trypanosoma brucei‘ Selecting our T. brucei RNAi library … Continue reading →

Back in 2012, we published our study decoding the anti-T. brucei drug efficacy determinants – or parasite proteins critical to drug action, such as drug transporters and activators. This identified a slew of proteins that drive the action of the … Continue reading →

After leaving David Horn’s lab almost four years ago in August 2013, when David and his group moved to the University of Dundee, we’re still managing to publish papers together. That’s the consequence of spending ten years in the same small but … Continue reading →

Suramin is one of the oldest drugs still in use today – it’s been used to treat early stage human African trypanosomiasis caused by T. b. rhodesiense since the early 1920s. Back in 2012 we showed that suramin uptake was dependent on … Continue reading →

Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei. PLoS Pathogens 10: e1004130 Featured at: LSHTM, Wellcome Trust See also: commentary in Microbial Cell 1:270-2 Most African trypanosomes, including the veterinary species Trypanosoma brucei brucei and T. congolense (causative agents of the … Continue reading →

Receptor mediated endocytosis for drug delivery in African trypanosomes: fulfilling Paul Ehrlich’s vision of chemotherapy (featured on the front cover of the May 2013 edition of Trends in Parasitology) A lot of time is spent identifying candidate drug targets and … Continue reading →

Genetic dissection of drug resistance in trypanosomes | Full Text Part of a special edition of Parasitology, 140(12):  Genetic and genomic approaches to understanding drug resistance in parasites (October, 2013). Our understanding of the routes to drug resistance in trypanosomes, … Continue reading →